University of Miami division of clinical pharmacology therapeutic rounds

Update on diagnosis and treatment of gastroparesis

Swati Agrawal, Neil H. Stollman, Arvey I. Rogers

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Gastroparesis, defined as delayed gastric emptying because of abnormal gastric motility in the absence of mechanical outlet obstruction, is a common problem causing significant morbidity. Although many cases are caused by diabetes, more than 90 different conditions are known to interfere with normal gastric motor function (Scand J Gastroenterol 1995;30[suppl]:7-16). Patients may present with nausea, vomiting, heartburn, early satiety, or postprandial pain. The current gold standard for quantifying gastric emptying is nuclear scintigraphy. The main goal of treatment is to improve patient comfort by accelerating the rate of gastric emptying, which may be achieved through dietary changes and the use of prokinetic agents. In rare instances, relief can only be obtained with surgical intervention. This report reviews the pathophysiology, clinical presentation, evaluation, and treatment of patients with gastroparesis, an understanding of which will lead to more effective patient care.

Original languageEnglish
Pages (from-to)97-109
Number of pages13
JournalAmerican Journal of Therapeutics
Volume6
Issue number2
StatePublished - Mar 1 1999
Externally publishedYes

Fingerprint

Gastroparesis
Clinical Pharmacology
Gastric Emptying
Stomach
Heartburn
Radionuclide Imaging
Nausea
Vomiting
Patient Care
Therapeutics
Morbidity
Pain

Keywords

  • Gastric emptying
  • Gastrointestinal motility
  • Gastroparesis

ASJC Scopus subject areas

  • Pharmacology

Cite this

University of Miami division of clinical pharmacology therapeutic rounds : Update on diagnosis and treatment of gastroparesis. / Agrawal, Swati; Stollman, Neil H.; Rogers, Arvey I.

In: American Journal of Therapeutics, Vol. 6, No. 2, 01.03.1999, p. 97-109.

Research output: Contribution to journalArticle

@article{54a9b397fb854aa5abf8b612234bb69a,
title = "University of Miami division of clinical pharmacology therapeutic rounds: Update on diagnosis and treatment of gastroparesis",
abstract = "Gastroparesis, defined as delayed gastric emptying because of abnormal gastric motility in the absence of mechanical outlet obstruction, is a common problem causing significant morbidity. Although many cases are caused by diabetes, more than 90 different conditions are known to interfere with normal gastric motor function (Scand J Gastroenterol 1995;30[suppl]:7-16). Patients may present with nausea, vomiting, heartburn, early satiety, or postprandial pain. The current gold standard for quantifying gastric emptying is nuclear scintigraphy. The main goal of treatment is to improve patient comfort by accelerating the rate of gastric emptying, which may be achieved through dietary changes and the use of prokinetic agents. In rare instances, relief can only be obtained with surgical intervention. This report reviews the pathophysiology, clinical presentation, evaluation, and treatment of patients with gastroparesis, an understanding of which will lead to more effective patient care.",
keywords = "Gastric emptying, Gastrointestinal motility, Gastroparesis",
author = "Swati Agrawal and Stollman, {Neil H.} and Rogers, {Arvey I.}",
year = "1999",
month = "3",
day = "1",
language = "English",
volume = "6",
pages = "97--109",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - University of Miami division of clinical pharmacology therapeutic rounds

T2 - Update on diagnosis and treatment of gastroparesis

AU - Agrawal, Swati

AU - Stollman, Neil H.

AU - Rogers, Arvey I.

PY - 1999/3/1

Y1 - 1999/3/1

N2 - Gastroparesis, defined as delayed gastric emptying because of abnormal gastric motility in the absence of mechanical outlet obstruction, is a common problem causing significant morbidity. Although many cases are caused by diabetes, more than 90 different conditions are known to interfere with normal gastric motor function (Scand J Gastroenterol 1995;30[suppl]:7-16). Patients may present with nausea, vomiting, heartburn, early satiety, or postprandial pain. The current gold standard for quantifying gastric emptying is nuclear scintigraphy. The main goal of treatment is to improve patient comfort by accelerating the rate of gastric emptying, which may be achieved through dietary changes and the use of prokinetic agents. In rare instances, relief can only be obtained with surgical intervention. This report reviews the pathophysiology, clinical presentation, evaluation, and treatment of patients with gastroparesis, an understanding of which will lead to more effective patient care.

AB - Gastroparesis, defined as delayed gastric emptying because of abnormal gastric motility in the absence of mechanical outlet obstruction, is a common problem causing significant morbidity. Although many cases are caused by diabetes, more than 90 different conditions are known to interfere with normal gastric motor function (Scand J Gastroenterol 1995;30[suppl]:7-16). Patients may present with nausea, vomiting, heartburn, early satiety, or postprandial pain. The current gold standard for quantifying gastric emptying is nuclear scintigraphy. The main goal of treatment is to improve patient comfort by accelerating the rate of gastric emptying, which may be achieved through dietary changes and the use of prokinetic agents. In rare instances, relief can only be obtained with surgical intervention. This report reviews the pathophysiology, clinical presentation, evaluation, and treatment of patients with gastroparesis, an understanding of which will lead to more effective patient care.

KW - Gastric emptying

KW - Gastrointestinal motility

KW - Gastroparesis

UR - http://www.scopus.com/inward/record.url?scp=0033047076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033047076&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 97

EP - 109

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 2

ER -